F. Di Salvo

2.1k citations
16 papers · 150 indexed · h-index 9
Topics
Breast Cancer Treatment Studies (6 papers)Global Cancer Incidence and Screening (4 papers)Air Quality and Health Impacts (3 papers)

In The Last Decade

F. Di Salvo

14 papers receiving 150 citations

Peers

F. Di Salvo
Comparison fields: 5 of 57
  • Cancer Research 65
  • Oncology 63
  • Radiology, Nuclear Medicine and Imaging 33
  • Pathology and Forensic Medicine 24
  • Health, Toxicology and Mutagenesis 20
Replace Ingrid Potyka with:
Ingrid Potyka United Kingdom
Calogero Mazzara Switzerland
Elena Leinert Germany
Ivan Golovanov United States
Abdulla Alhasso United Kingdom
Matthew T. Warkentin Canada
Antonio Golpe-Gómez Spain
Paulo De Sousa United Kingdom
Nikhil Sapre Australia
Adeyinka Ademola Nigeria
F. Di Salvo relative to Ingrid Potyka United Kingdom Ingrid Potyka's profile →
Citations per field
00.5×1.5×1.9×
Ingrid Potyka · 1×
Citations per year

Countries citing papers authored by F. Di Salvo

Since Specialization
Citations

This map shows the geographic impact of F. Di Salvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Di Salvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Di Salvo more than expected).

Fields of papers citing papers by F. Di Salvo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Di Salvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Di Salvo. The network helps show where F. Di Salvo may publish in the future.

Co-authorship network of co-authors of F. Di Salvo

This figure shows the co-authorship network connecting the top 25 collaborators of F. Di Salvo. A scholar is included among the top collaborators of F. Di Salvo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Di Salvo. F. Di Salvo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 0
2 6
3 11
4 15
5 9
6 9
7 1
8 34
9 6
10 12
11 0
12 21
13 4
14 10
15 8
16 4

About F. Di Salvo

F. Di Salvo is a scholar working on Cancer Research, Oncology and Health, Toxicology and Mutagenesis, having authored 16 papers that have together received 150 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Global Cancer Incidence and Screening (4 papers) and Air Quality and Health Impacts (3 papers). The work is most often cited by research in Cancer Research (65 citations), Oncology (63 citations) and Radiation (17 citations). F. Di Salvo has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Paolo Baili, Andrea Micheli, Milena Sant, Serena Di Cosimo, Maria Carmen De Santis, E. Pignoli, Donatella Ugolini, Laura Lozza, Claudio Lombardo and R. Valdagni. Their work appears in journals such as Annals of Oncology, European Journal of Cancer and Environmental Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026